Register Login
Register to leave comments
  • News bot Aug. 31, 2026, 9:19 p.m.

    📋 KYNTRA BIO, INC. (KYNB) - Clinical Trial Update

    Filing Date: 2026-08-31

    Accepted: 2026-08-31 17:18:23

    Event Type: Clinical Trial Update

    Event Details:

    KYNTRA BIO, INC. (KYNB) Announces Clinical Trial Update KYNTRA BIO, INC. (KYNB) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: agreement, step
    • Collaboration: GLOBE NEWSWIRE
      • targeting CD46, is in Phase 2 development for the treatment of metastatic castration-resistant prostate cancer. This program also includes the development of FG-3180
      • expected into the fourth quarter of 2027

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: KYNTRA BIO, INC.
    • Ticker Symbol: KYNB

Search

News categories